(BUSINESS WIRE)-- Nuvera Biosciences is developing molecular diagnostic tests that will help significantly improve treatment selection and quality of patient management in cancer. The Company has developed of four gene-based breast cancer tests for determining individual patient response to standard-of-care therapy. The tests have been clinically validated with trials at MD Anderson Cancer Center, a founding partner and other leading cancer centers worldwide.
